CLE mutation decreases H3K27me3 levels on the viral IR. by Jacqueline Williams (3493745)

Delayed E46K αSyn degradation compared with WT αSyn degradation. by Ryusuke Sakai (2961507)

“…A decrease in undegraded WT αSyn protein levels was observed on day 4, whereas E46K protein levels remained almost unchanged. …”

Silencing of VPS38/UVRAG and ATG14 does not alter oviposition but decreases embryo viability. by Priscila H. Vieira (5228207)

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. by Orna Mizrahi-Man (42539)

NbNBR1 decreases the ubiquitination level of total protein after TYLCCNV/TYLCCNB infection. by Tingting Zhou (163678)

NeuN expression and neuronal apoptosis in Sham and severely injured groups. by Xinhui Zhang (1624039)

Longer polyQ sequences increase the tendency of AR to localize to nuclear puncta in the presence of DHT. by Carlos M. Roggero (11909585)

Pairwise correlations of excitatory neurons in APP/PS1 mice are decreased in dCA1, but increased in vCA1. by Udaysankar Chockanathan (18510288)

Means for STEM competence for pre- and post-test. by Esther Kim (2996622)

Data Sheet 1_Decreased neuronal excitability in hypertriglyceridemia hamsters with acute seizures.docx by Qiuyue Shen (20373266)

Absorbed lifetime and 50-y projected doses to selected organs. by Martin Šefl (11607984)

JBPOS0101 decreased Amyloid Beta (Aβ) aggregates in the cortex and hippocampal regions in 5xFAD mouse brains. by Jihoon Jeong (4852690)

Alterations in fat body Lsd1 and Lsd2 levels upon the genetic increase or decrease in cardiac Snail TF levels. by Ying Liu (18461)

IODVA1 inhibits lamellipodia and circular dorsal ruffle (CDR) formation in MDA-MB-231 cells and decreases Rac activation. by Anjelika Gasilina (8566296)

Silencing of RCC1L isoforms alter the levels of mitochondrial ribosomal proteins and biogenesis factors resulting in decreased mitochondrial translation. by Aurelio Reyes (412135)

K2 treatment does not visibly affect LPS structure. by Estelle Ifrid (10076719)

Subjects:

Image_1_Decreased Compressional Sound Velocity Is an Indicator for Compromised Bone Stiffness in X-Linked Hypophosphatemic Rickets (XLH).TIFF by Adalbert Raimann (469799)

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

“…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i>_d,RIPK1 = 8.6 nM, <i>K</i>_d,RIPK3 > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC₅₀ = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …”

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

“…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i>_d,RIPK1 = 8.6 nM, <i>K</i>_d,RIPK3 > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC₅₀ = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …”

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

“…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i>_d,RIPK1 = 8.6 nM, <i>K</i>_d,RIPK3 > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC₅₀ = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …”